AtheroGenics Converts Ch. 7 Bankruptcy Into Ch. 11
Blaming a "substantial debt burden" that has threatened the development of a key diabetes drug, pharmaceutical company AtheroGenics Inc. asked a court on Monday to convert an involuntary Chapter 7 petition...To view the full article, register now.
Already a subscriber? Click here to view full article